A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

BackgroundGlioblastoma patients administered standard therapies, comprising maximal surgical resection, radiation therapy with concomitant and adjuvant temozolomide, have a variable prognosis with a median overall survival of 15–16 months and a 2-year overall survival of 30%. The aim of this study w...

Full description

Bibliographic Details
Main Authors: Armita Armina Abedi, Kirsten Grunnet, Ib Jarle Christensen, Signe Regner Michaelsen, Aida Muhic, Søren Møller, Benedikte Hasselbalch, Hans Skovgaard Poulsen, Thomas Urup
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
glioma grade IV
nomogram
prognostic factors
overall survival
progression-free survival
glioblastoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.597587/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.597587/full

Similar Items